Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Fraser

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Inflammatory Bowel Diseases|June 12, 2018
MicroRNA-31 Targets Thymic Stromal Lymphopoietin in Mucosal Infiltrated CD4+ T Cells: A Role in Achieving Mucosal Healing in Ulcerative Colitis?Simon R Whiteoak, Andrew Claridge, Clare A Balendran, et al.
Inflammatory Bowel Diseases|April 25, 2007
Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility geneJ R Fraser Cummings, Rachel Cooney, Saad Pathan, et al.
Inflammatory Bowel Diseases|September 26, 2022
Prediction of Crohn's Disease Stricturing Phenotype Using a NOD2-derived Genomic BiomarkerJames J Ashton, Guo Cheng, Imogen S Stafford, et al.
BMJ Open Gastroenterology|November 14, 2020
High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learningMartin McDonnell, Richard J Harris, Florina Borca, et al.
Gastroenterology|October 11, 2019
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's DiseaseAleksejs Sazonovs, Nicholas A Kennedy, Loukas Moutsianas, et al.
Journal of Crohn'S & Colitis|June 5, 2020
Clinical Features and Genetic Risk of Demyelination Following Anti-TNF TreatmentSimeng Lin, Harry D Green, Peter Hendy, et al.
The Lancet. Gastroenterology & Hepatology|March 3, 2019
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort studyNicholas A Kennedy, Graham A Heap, Harry D Green, et al.
Science (New York, N.Y.)|November 19, 1993
Uncertainties in carbon dioxide radiative forcing in atmospheric general circulation modelsR D Cess, M H Zhang, G L Potter, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring studyNeil Chanchlani, Simeng Lin, Marcus K Auth, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Inflammatory Bowel Diseases|June 12, 2018
MicroRNA-31 Targets Thymic Stromal Lymphopoietin in Mucosal Infiltrated CD4+ T Cells: A Role in Achieving Mucosal Healing in Ulcerative Colitis?Simon R Whiteoak, Andrew Claridge, Clare A Balendran, et al.
Inflammatory Bowel Diseases|April 25, 2007
Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility geneJ R Fraser Cummings, Rachel Cooney, Saad Pathan, et al.
Inflammatory Bowel Diseases|September 26, 2022
Prediction of Crohn's Disease Stricturing Phenotype Using a NOD2-derived Genomic BiomarkerJames J Ashton, Guo Cheng, Imogen S Stafford, et al.
BMJ Open Gastroenterology|November 14, 2020
High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learningMartin McDonnell, Richard J Harris, Florina Borca, et al.
Gastroenterology|October 11, 2019
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's DiseaseAleksejs Sazonovs, Nicholas A Kennedy, Loukas Moutsianas, et al.
Journal of Crohn'S & Colitis|June 5, 2020
Clinical Features and Genetic Risk of Demyelination Following Anti-TNF TreatmentSimeng Lin, Harry D Green, Peter Hendy, et al.
The Lancet. Gastroenterology & Hepatology|March 3, 2019
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort studyNicholas A Kennedy, Graham A Heap, Harry D Green, et al.
Science (New York, N.Y.)|November 19, 1993
Uncertainties in carbon dioxide radiative forcing in atmospheric general circulation modelsR D Cess, M H Zhang, G L Potter, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring studyNeil Chanchlani, Simeng Lin, Marcus K Auth, et al.
Pageof 17